VGXI Gears To Support Production Of New Coronavirus Vaccine

Initial Manufacturing Of Inovio/Advaccine Candidate

 
• By Jung Won Shin

VGXI, a contract manufacturer of plasmid DNA and US subsidiary of Korea’s GeneOne Life Science, joins in the R&D efforts for a DNA vaccine against the new Wuhan coronavirus, using its proprietary manufacturing platform as part of a new agreement with Inovio.

Syringe_Vial_Vaccine
Increasing Efforts To Develop Vaccines Against New Coronavirus • Source: Shutterstock

More from Anti-infective

More from Therapy Areas